Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1;45(2):261-266.
doi: 10.2337/dc21-2216.

ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes

John J Nolan  1 , Anna R Kahkoska  2 , Zhila Semnani-Azad  3 , Marie-France Hivert  4 , Linong Ji  5 , Viswanathan Mohan  6 , Robert H Eckel  7 , Louis H Philipson  8 , Stephen S Rich  9 , Chandra Gruber  10 , Paul W Franks  11   12   13
Affiliations
Review

ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes

John J Nolan et al. Diabetes Care. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key milestones and timelines of the ADA/EASD PMDI. Adapted from Chung et al. (1). RFA, request for applications.
Figure 2
Figure 2
Key steps in the iterative process of implementing the PDMI into clinical practice.
Figure 3
Figure 3
Overview of key stakeholders germane to the success of the ADA/EASD PMDI. IT, information technology; pharma, pharmaceutical industry; med tech, medical technology; data sci, data science.
See this image and copyright information in PMC

References

    1. Chung WK, Erion K, Florez JC, et al. . Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:1617–1635 - PMC - PubMed
    1. Pearson E. Precision treatment in type 2 diabetes: can we predict response and outcomes to diabetes therapies? PDM2021: a virtual conference. Day 3, workshop 1. Accessed 4 November 2021. Available from https://pdm2021.org/video/day3/workshop1/5.%20Ewan%20Pearson.mp4?ws1&tp52
    1. Flanagin A, Frey T; AMA Manual of Style Committee . Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 2021;326:621–627 - PubMed
    1. Ahlqvist E, Storm P, Käräjämäki A, et al. . Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018;6:361–369 - PubMed
    1. Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol 2019;7:9–11 - PubMed

Publication types